Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Interventional × golimumab × Clear all

Phase

Status

Sponsor Class

OTHER 3 INDUSTRY 3 NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 1 1

Interventions

Cyclophosphamide 351 Specimen Handling 326 Magnetic Resonance Spectroscopy 286 Radiotherapy 279 Biopsy 239 Cisplatin 236 Carboplatin 223 Paclitaxel 202 Doxorubicin 201 Fluorouracil 181 Etoposide 181 Vincristine 170 Bevacizumab 168 Filgrastim 155 Gemcitabine 148 Leucovorin 134 Cytarabine 133 aldesleukin 127 Docetaxel 110 Taxes 104 fludarabine phosphate 101 Rituximab 101 Oxaliplatin 101 Chemotherapy, Adjuvant 100 Prednisone 94 Irinotecan 93 Bortezomib 93 Radiation 92 Methotrexate 92 Peripheral Blood Stem Cell Transplantation 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04729296 2021-12-02

Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2 Withdrawn

Diabetes Mellitus, Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡